These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 27272940)

  • 1. Protective effects of a Modified Vaccinia Ankara-based vaccine candidate against Crimean-Congo Haemorrhagic Fever virus require both cellular and humoral responses.
    Dowall SD; Graham VA; Rayner E; Hunter L; Watson R; Taylor I; Rule A; Carroll MW; Hewson R
    PLoS One; 2016; 11(6):e0156637. PubMed ID: 27272940
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Crimean-Congo hemorrhagic fever (CCHF) viral vaccine expressing nucleoprotein is immunogenic but fails to confer protection against lethal disease.
    Dowall SD; Buttigieg KR; Findlay-Wilson SJ; Rayner E; Pearson G; Miloszewska A; Graham VA; Carroll MW; Hewson R
    Hum Vaccin Immunother; 2016; 12(2):519-27. PubMed ID: 26309231
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel vaccine against Crimean-Congo Haemorrhagic Fever protects 100% of animals against lethal challenge in a mouse model.
    Buttigieg KR; Dowall SD; Findlay-Wilson S; Miloszewska A; Rayner E; Hewson R; Carroll MW
    PLoS One; 2014; 9(3):e91516. PubMed ID: 24621656
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Crimean-Congo hemorrhagic fever: current and future prospects of vaccines and therapies.
    Keshtkar-Jahromi M; Kuhn JH; Christova I; Bradfute SB; Jahrling PB; Bavari S
    Antiviral Res; 2011 May; 90(2):85-92. PubMed ID: 21362441
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A DNA vaccine for Crimean-Congo hemorrhagic fever protects against disease and death in two lethal mouse models.
    Garrison AR; Shoemaker CJ; Golden JW; Fitzpatrick CJ; Suschak JJ; Richards MJ; Badger CV; Six CM; Martin JD; Hannaman D; Zivcec M; Bergeron E; Koehler JW; Schmaljohn CS
    PLoS Negl Trop Dis; 2017 Sep; 11(9):e0005908. PubMed ID: 28922426
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunization with DNA Plasmids Coding for Crimean-Congo Hemorrhagic Fever Virus Capsid and Envelope Proteins and/or Virus-Like Particles Induces Protection and Survival in Challenged Mice.
    Hinkula J; Devignot S; Åkerström S; Karlberg H; Wattrang E; Bereczky S; Mousavi-Jazi M; Risinger C; Lindegren G; Vernersson C; Paweska J; van Vuren PJ; Blixt O; Brun A; Weber F; Mirazimi A
    J Virol; 2017 May; 91(10):. PubMed ID: 28250124
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nucleoside-Modified mRNA Vaccines Protect IFNAR
    Appelberg S; John L; Pardi N; Végvári Á; Bereczky S; Ahlén G; Monteil V; Abdurahman S; Mikaeloff F; Beattie M; Tam Y; Sällberg M; Neogi U; Weissman D; Mirazimi A
    J Virol; 2022 Feb; 96(3):e0156821. PubMed ID: 34817199
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adenoviral vectored vaccination protects against Crimean-Congo Haemorrhagic Fever disease in a lethal challenge model.
    Saunders JE; Gilbride C; Dowall S; Morris S; Ulaszewska M; Spencer AJ; Rayner E; Graham VA; Kennedy E; Thomas K; Hewson R; Gilbert SC; Belij-Rammerstorfer S; Lambe T
    EBioMedicine; 2023 Apr; 90():104523. PubMed ID: 36933409
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of the cell culture based and the mouse brain derived inactivated vaccines against Crimean-Congo hemorrhagic fever virus in transiently immune-suppressed (IS) mouse model.
    Pavel STI; Yetiskin H; Kalkan A; Ozdarendeli A
    PLoS Negl Trop Dis; 2020 Nov; 14(11):e0008834. PubMed ID: 33226988
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nucleocapsid protein-based vaccine provides protection in mice against lethal Crimean-Congo hemorrhagic fever virus challenge.
    Zivcec M; Safronetz D; Scott DP; Robertson S; Feldmann H
    PLoS Negl Trop Dis; 2018 Jul; 12(7):e0006628. PubMed ID: 30011277
    [TBL] [Abstract][Full Text] [Related]  

  • 11. GEM-PA-Based Subunit Vaccines of Crimean Congo Hemorrhagic Fever Induces Systemic Immune Responses in Mice.
    Wang Q; Wang S; Shi Z; Li Z; Zhao Y; Feng N; Bi J; Jiao C; Li E; Wang T; Wang J; Jin H; Huang P; Yan F; Yang S; Xia X
    Viruses; 2022 Jul; 14(8):. PubMed ID: 36016285
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Towards an understanding of the migration of Crimean-Congo hemorrhagic fever virus.
    Mild M; Simon M; Albert J; Mirazimi A
    J Gen Virol; 2010 Jan; 91(Pt 1):199-207. PubMed ID: 19812264
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bovine Herpesvirus Type 4 (BoHV-4) Vector Delivering Nucleocapsid Protein of Crimean-Congo Hemorrhagic Fever Virus Induces Comparable Protective Immunity against Lethal Challenge in IFNα/β/γR-/- Mice Models.
    Aligholipour Farzani T; Földes K; Hanifehnezhad A; Yener Ilce B; Bilge Dagalp S; Amirzadeh Khiabani N; Ergünay K; Alkan F; Karaoglu T; Bodur H; Ozkul A
    Viruses; 2019 Mar; 11(3):. PubMed ID: 30857305
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vesicular Stomatitis Virus-Based Vaccine Protects Mice against Crimean-Congo Hemorrhagic Fever.
    Rodriguez SE; Cross RW; Fenton KA; Bente DA; Mire CE; Geisbert TW
    Sci Rep; 2019 May; 9(1):7755. PubMed ID: 31123310
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Crimean-Congo haemorrhagic fever in travellers: A systematic review.
    Leblebicioglu H; Ozaras R; Fletcher TE; Beeching NJ;
    Travel Med Infect Dis; 2016; 14(2):73-80. PubMed ID: 26970396
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Crimean-Congo haemorrhagic fever in Eurasia.
    Leblebicioglu H
    Int J Antimicrob Agents; 2010 Nov; 36 Suppl 1():S43-6. PubMed ID: 20810253
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunization of knock-out α/β interferon receptor mice against high lethal dose of Crimean-Congo hemorrhagic fever virus with a cell culture based vaccine.
    Canakoglu N; Berber E; Tonbak S; Ertek M; Sozdutmaz I; Aktas M; Kalkan A; Ozdarendeli A
    PLoS Negl Trop Dis; 2015 Mar; 9(3):e0003579. PubMed ID: 25760444
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Crimean-Congo haemorrhagic fever: an enemy at the gates].
    Pittalis S; Meschi S; Castilletti MC; Di Caro A; Puro V
    Infez Med; 2009 Sep; 17(3):133-40. PubMed ID: 19838084
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of a Novel Multi-Epitope Vaccine Against Crimean-Congo Hemorrhagic Fever Virus: An Integrated Reverse Vaccinology, Vaccine Informatics and Biophysics Approach.
    Tahir Ul Qamar M; Ismail S; Ahmad S; Mirza MU; Abbasi SW; Ashfaq UA; Chen LL
    Front Immunol; 2021; 12():669812. PubMed ID: 34220816
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epidemiological and behavioral factors associated with Crimean-Congo hemorrhagic fever virus infections in humans.
    Sargianou M; Papa A
    Expert Rev Anti Infect Ther; 2013 Sep; 11(9):897-908. PubMed ID: 24053271
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.